Solage

Solage is a brand name of mequinol/tretinoin topical, approved by the FDA in the following formulation(s):

SOLAGE (mequinol; tretinoin - solution; topical)

• 
  Manufacturer: AQUA PHARMS
  
  Approval date: December 10, 1999
  
  Strength(s): 2%;0.01% ^[RLD]

Has a generic version of Solage been approved?

No. There is currently no therapeutically equivalent version of Solage available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Solage. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Synergistic skin depigmentation composition
  Patent 5,194,247
  Issued: March 16, 1993
  Inventor(s): Nair; Xina & Tramposch; Kenneth M.
  There is disclosed a synergistic composition for skin depigmentation with reduced irritation which does not contain a corticosteroid comprising 4-hydroxyanisole and a retinoid, such as all-trans retinoic acid, 11-cis,13-cis-12-hydroxymethyl retinoic acid .delta.-lactone or (N-acetyl-4-aminophenyl) retinoate, in a pharmaceutically acceptable topical vehicle.
  
  Patent expiration dates:
  
  
  • December 10, 2013
    
    ✓ 
    Patent use: TREATMENT OF HYPERPIGMENTARY DISORDERS
    ✓ 
    Drug product
  
  



• 
  Storage stable tretinoin and 4-hydroxyanisole containing topical composition
  Patent 6,353,029
  Issued: March 5, 2002
  Inventor(s): Prakash V.; Parab
  Assignee(s): Bristol-Myers Squibb Company
  A long-term storage stable tretinoin and 4-hydroxyanisole composition contains low molecular weight polyethylene glycol, antioxidant, a chelating agent, lower alkanol and water. The chelating agent provides at least two of the functions of oxygen scavaging, free radical chain terminating and reducing. The composition has a pH of 2.5 to 5 and a water content of at least 12%.
  
  Patent expiration dates:
  
  
  • August 24, 2020
    
  
  

See also...

• Solage Consumer Information (Wolters Kluwer)
• Solage Consumer Information (Cerner Multum)
• Solage Topical Advanced Consumer Information (Micromedex)
• Mequinol/Tretinoin Consumer Information (Wolters Kluwer)
• Mequinol and tretinoin topical Consumer Information (Cerner Multum)
• Mequinol and tretinoin Topical Advanced Consumer Information (Micromedex)